Turmeric supplements may offer little or no pain relief for people with knee arthritis, according to researchers. An international team conducting a Cochrane review found that the spice, commonly used in Asian cooking, does not ease symptoms as previously thought.
Turmeric contains curcuminoids, including curcumin, which have anti-inflammatory properties and were believed to help with osteoarthritis, the most common form of arthritis. The review analysed nine existing studies involving 1,245 people with knee osteoarthritis, comparing turmeric supplements with a placebo, non-steroidal anti-inflammatory drugs such as ibuprofen and diclofenac, and paracetamol.
Study Details and Findings
The studies examined various turmeric extracts and curcuminoid-based products at different strengths and doses. Participants averaged 52 to 62 years old, with around two-thirds being women. Research was conducted in Australia, Belgium, India, and Thailand.
Cochrane noted the trials were relatively short, lasting between four weeks and three months. Combined results showed turmeric was not more effective than a placebo or anti-inflammatory drugs. However, the team acknowledged that some studies had limitations and that the available evidence remains uncertain.
Expert Commentary
Dr Ivan Shirinsky, lead author and practicing rheumatologist, said: “As a clinician and researcher, I am not surprised by these findings.” He added that osteoarthritis is a complex and still incompletely understood disease, with limited effective pharmacological options.
Dr Shirinsky stated he would not routinely recommend turmeric supplements to his patients with knee osteoarthritis. He noted that if a patient asked, he would explain what is known and what remains uncertain about benefits and potential harms to help them make an informed decision.
Trustworthiness Concerns
Previous reviews suggested turmeric might improve pain and physical function in osteoarthritis patients, but Cochrane raised concerns about the trustworthiness of 10 of those trials and excluded them from the final analysis. Dr Shirinsky said the review highlights the importance of assessing the trustworthiness of clinical trials, as such assessments help identify studies requiring further clarification before their findings inform conclusions about treatment effects.